Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 27, 2017

View Archived Issues

Medivir reports promising topline data on MIV-711 in knee osteoarthritis

New Chiesi inhaled corticosteroid displays potency in airway inflammation models

Atopic asthma model devised in Sprague-Dawley rats using S. aureus enterotoxin B

ALM-201 is safe in phase I trial in patients with advanced solid tumors

Catalyst Biosciences' CB-2679d awarded FDA orphan drug status for hemophilia B

Fibrocell Sciences reports interim results of phase I/II study of FCX-007

Sputum PZP found to be a possible biomarker of bronchiectasis severity

Manageable safety seen with SL-801 in phase I trial

Pluristem planning phase III study of PLX-PAD cells for muscle recovery after arthroplasty

Genocea Biosciences to focus on neoantigen cancer vaccines

Asterias Biotherapeutics cleared to conduct clinical trials of allogenic cancer immunotherapy

vTv Therapeutics patents compounds for treating Alzheimer's disease

Poseida Therapeutics begins enrollment in phase I study of CAR T-cell therapy for multiple myeloma

Bayer Pharma identifies novel PGF receptor antagonists

Merck & Co. presents muscarinic M1 receptor modulators

Muscarinic M1 receptor PAMs described in Takeda patent

Novel tyrosine kinase inhibitors presented by NIBS

FDA accepts IND for Ocugen's OCU-310, proof-of-concept study begins

Acer Therapeutics reports results from pivotal study of Edsivo in vascular Ehlers-Danlos syndrome

EMA grants orphan drug designation to EDIT-101 for LCA10

Japanese approval for Cedarcure SLIT for Japanese cedar allergy

Phase I results for MOR-106 in patients with atopic dermatitis

Phase III study of intepirdine in Alzheimer's diseases misses co-primary efficacy endpoints

Herantis initiates first-in-human study of CDNF in Parkinson's disease

ImaginAb collaborates with Boehringer Ingelheim on CD8 T-cell imaging technology

Pfizer obtains approval for Ibrance in Japan

Topline results reported from Japanese phase II study of vadadustat in NDD-CKD

New mutation in SYNGAP1 gene tied to Ohtahara syndrome

Mateon terminates FOCUS study of CA4P for ovarian cancer

Darzalex approved in Japan for relapsed or refractory multiple myeloma

Maviret approved in Japan

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...